International group urges prompt HIV treatment for all

July 22, 2012

An international group of scientists on Sunday called for all adults who test positive for HIV to be treated with antiretroviral drugs right away rather than waiting for their immune systems to weaken.

The recommendations by the International Antiviral Society are the first by a global group to make such a call, and were released at the 19th International AIDS Conference in Washington, the world's largest meeting on HIV/AIDS.

Other major groups, such as the , currently urge treatment after the disease progresses to a certain point, or when the body's T-cells, or CD4 count, reaches or falls below the level of 350 cells/mm3.

"These guidelines are aspirational," said Melanie Thompson, a doctor with the AIDS Research Consortium of Atlanta, urging increased testing and better care of those who test positive for HIV.

The guidelines are based on new trial data and that have become available in the last two years which warrant an "update to guidelines for antiretroviral treatment in HIV-infected adults in resource-rich settings."

Some 34 million people in the world are living with HIV, according to the latest UNAIDS report issued last week. However, about one in five people are not aware of their status and are most at risk of .

Some eight million people in low and are now on antiretroviral treatment, making up about half of those in the world who need it, the UNAIDS report said.

"Unfortunately most people in the world are not going to benefit from our ," Thompson said, noting that most people seek care too late, by the time they already have full-blown AIDS.

Asked by a reporter if the guidelines were realistic in the current global cash-crunch environment, Thompson replied: "I actually reject the idea that there is not enough money for care and for drugs for antiretroviral therapy.

"I think it is a matter of political will. I think it is a matter of prioritizing and recognizing that treatment of HIV is cost-effective. It may be cost-saving as well," she said.

"The science should drive the allocation of resources and guidelines can play an important role in that respect."

The full guidelines are published in Sunday's theme issue of the Journal of the American Medical Association, which focuses on HIV/AIDS.

Explore further: Among new HIV treatment recommendations, all adult patients should be offered antiretroviral therapy

Related Stories

Among new HIV treatment recommendations, all adult patients should be offered antiretroviral therapy

July 22, 2012
Included in the 2012 International Antiviral Society-USA panel recommendations for human immunodeficiency virus (HIV) patient care is that all adult patients, regardless of CD4 cell count, should be offered antiretroviral ...

Facts about HIV/AIDS worldwide in 2011

July 18, 2012
Here are some key facts and figures on HIV/AIDS in 2011, released by UNAIDS on Wednesday ahead of the International AIDS Conference set to take place in Washington on July 22-27.

Many Americans with HIV go untreated: study

November 29, 2011
Nearly three quarters of the 1.2 million Americans with HIV do not have their infection under control, raising the risk of death from AIDS and transmission to others, said a US study on Tuesday.

Hope for more options in couples where one partner is HIV positive

November 15, 2011
In sub-Saharan Africa, couples in long-term relationships where one partner is HIV-positive and the other is HIV-negative (HIV serodiscordant couples) could benefit from anti-AIDS drugs (antiretroviral therapy) given either ...

Recommended for you

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.